Guided Therapeutics Inc logo

Guided Therapeutics Inc

$ 0.47 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 17.14M
Enterprise V:
$ 24.97M
Volume:
300.00
Avg Vol (2M):
3.57K
Volume:
300.00
Market Cap $:
17.14M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.57K
Enterprise Value $:
24.97M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
Name Current Vs Industry Vs History
Cash-To-Debt 0.15
Equity-to-Asset -3.84
Debt-to-Equity -0.53
Debt-to-EBITDA -12.09
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -137.76
Distress
Grey
Safe
Beneish M-Score -5.03
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 12.46
9-Day RSI 28.52
14-Day RSI 37.67
6-1 Month Momentum % -15.01
12-1 Month Momentum % -8.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.18
Quick Ratio 0.09
Cash Ratio 0.07
Days Inventory 3451.02
Days Sales Outstanding 142.52
Days Payable 13946.53

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -72.4

Financials

GTHP's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:GTHP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.084
EPS (TTM) ($) -0.084
Beta 0.82
Volatility % 43.06
14-Day RSI 37.67
14-Day ATR ($) 0.044046
20-Day SMA ($) 0.532875
12-1 Month Momentum % -8.06
52-Week Range ($) 0.328 - 0.7799
Shares Outstanding (Mil) 36.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Guided Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Guided Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.